2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Revenue | CN¥8.6B | CN¥4B | CN¥4.5B | CN¥3.4B | CN¥4.9B |
Cost of Revenue | CN¥665M | CN¥1.1B | CN¥761M | CN¥777M | CN¥976M |
Gross Profit | CN¥8B | CN¥2.9B | CN¥3.7B | CN¥2.7B | CN¥3.9B |
Gross Profit % | 92% | 72% | 83% | 77% | 80% |
R&D Expenses | CN¥0 | CN¥0 | CN¥208M | CN¥152M | CN¥149M |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Net Income | CN¥1.2B | -CN¥693M | CN¥1B | CN¥1.2B | CN¥2.1B |
Dep. & Amort. | CN¥395M | CN¥327M | CN¥140M | CN¥53M | CN¥25M |
Def. Tax | CN¥0 | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
Stock Comp. | CN¥44M | CN¥14M | CN¥19M | CN¥22M | CN¥6.8M |
Chg. in WC | -CN¥2.5B | -CN¥152M | -CN¥1.5B | CN¥467M | -CN¥352M |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Cash | CN¥3.2B | CN¥2.5B | CN¥2.9B | CN¥4.3B | CN¥5.8B |
ST Investments | CN¥461M | CN¥176M | CN¥177M | CN¥973M | CN¥514M |
Cash & ST Inv. | CN¥3.7B | CN¥2.6B | CN¥3B | CN¥5.2B | CN¥6.2B |
Receivables | CN¥2.6B | CN¥2.6B | CN¥3.7B | CN¥2B | CN¥2B |
Inventory | -CN¥42M | CN¥1 | -CN¥493M | CN¥1 | CN¥0 |
YRD delivered strong 2024 results, with full-year loan volume reaching RMB 53.6 billion (up 49% YoY), and Q4 loan volume at RMB 15.4 billion (up 32% YoY); monthly active users on the Yixinhua platform grew 27% YoY to 4.5 million.
Asset quality improved, with a 13 basis point drop in first payment default rate and lower delinquency rates; M1 recovery rates hit a record high, and funding costs declined by 210 basis points YoY.
International business, especially in the Philippines, achieved profitability with monthly loan volumes of RMB 30–40 million; total international loan volume is expected to double in 2025, with expansion plans in other regions.
AI investment surged (RMB 412 million in R&D, up 177% YoY), driving operational efficiency, cost savings (RMB 44 million from AI funding routing), and improved customer service; 81% of day-one overdue cases handled by AI.
2024 full-year revenue grew 90% YoY, Q4 revenue up 40% YoY; net income for the year was RMB 1,582 million (down 24% YoY) due to higher R&D/marketing spend and insurance headwinds; 2025 revenue guidance is RMB 5.6–6.5 billion with a healthy net profit margin; cash dividend of $0.22/ADS announced and share repurchases continued.